Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
Vale SA
VALE
KB Home
KBH
Apple
AAPL
US Stock MarketDetailed Quotes
NKTR Nektar Therapeutics
- 0.9826
- +0.0908+10.18%
Close Feb 14 16:00 ET
- 1.0000
- +0.0174+1.77%
Post 20:01 ET
181.25MMarket Cap-1.17P/E (TTM)
1.0800High0.9005Low6.89MVolume0.9300Open0.8918Pre Close6.84MTurnover4.15%Turnover RatioLossP/E (Static)184.46MShares1.928052wk High3.71P/B162.94MFloat Cap0.630352wk Low--Dividend TTM165.83MShs Float111.3600Historical High--Div YieldTTM20.13%Amplitude0.4126Historical Low0.9930Avg Price1Lot Size
About Nektar Therapeutics Company
Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.
Company Profile
SymbolNKTR
Company NameNektar Therapeutics
Listing DateMay 6, 1994
Issue Price7.50
Founded1990
CEOMr. Howard W. Robin
MarketNASDAQ
Employees137
Fiscal Year Ends12-31
Address455 Mission Bay Boulevard South
CitySan Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94158
Phone1-415-482-5300
Websitehttp://www.nektar.com
Company Executives
- Name
- Position
- Salary
- Howard W. Robin
- Director, President and Chief Executive Officer
- 3.14M
- Mark Andrew Wilson, J.D.
- Senior Vice President and Chief Legal Officer
- 1.10M
- Sandra A. Gardiner
- Interim Chief Financial Officer and Principal Accounting Officer
- 376.30K
- Dr. Jonathan Zalevsky, PhD
- Chief Research and Development Officer
- 1.77M
- Robert B. Chess
- Chairman of the Board
- 176.22K
- Jeffrey R. Ajer
- Independent Director
- 134.22K
- Dr. Myriam J. Curet, M.D.
- Independent Director
- 118.22K
- R. Scott Greer
- Independent Director
- 170.22K
- Roy A. Whitfield
- Lead Independent Director
- 170.22K
- Dr. Diana M. Brainard, M.D.
- Independent Director
- 112.72K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
